pentetic acid has been researched along with Graves Disease in 9 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Graves Disease: A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Visualization of thyroidal and orbital Graves' disease is feasible, but further investigation is necessary to establish the role of [111In-DTPA-D-Phe1]octreotide scintigraphy in representing disease activity and expression and in predicting therapeutical outcome." | 1.29 | [111In-DTPA-D-Phe1] octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity? ( Hooijkaas, H; Kooy, PP; Krenning, EP; Oei, HY; Postema, PT; Reubi, JC; van den Bosch, WA; van der Loos, T; Wiersinga, WM; Wijngaarde, R, 1994) |
| "Seven patients with exophthalmos were investigated: six had GD while one was affected with a non small cell lung cancer (NSCLC)." | 1.29 | Indium-111 octreotide in Graves' disease and in the evaluation of active exophthalmos. ( Bizzarro, A; De Bellis, A; Del Vecchio, E; Di Martino, S; Mansi, L; Panza, N; Rambaldi, PF, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Savastano, S | 1 |
| Pivonello, R | 3 |
| Acampa, W | 1 |
| Salvatore, M | 1 |
| Lombardi, G | 3 |
| Colao, A | 3 |
| Fenzi, G | 3 |
| Alevizaki-Harhalaki, M | 1 |
| Alevizaki, C | 1 |
| Georgiou, E | 1 |
| Proukauis, C | 1 |
| Ikkos, D | 1 |
| Postema, PT | 2 |
| Krenning, EP | 3 |
| Wijngaarde, R | 1 |
| Kooy, PP | 1 |
| Oei, HY | 1 |
| van den Bosch, WA | 1 |
| Reubi, JC | 1 |
| Wiersinga, WM | 2 |
| Hooijkaas, H | 1 |
| van der Loos, T | 1 |
| Mansi, L | 1 |
| Rambaldi, PF | 1 |
| Bizzarro, A | 1 |
| Panza, N | 1 |
| Di Martino, S | 1 |
| De Bellis, A | 1 |
| Del Vecchio, E | 1 |
| Kwekkeboom, DJ | 1 |
| van Hagen, PM | 1 |
| Lastoria, S | 2 |
| Ferone, D | 2 |
| Macchia, PE | 1 |
| Vassallo, P | 1 |
| Bonavolonta, G | 1 |
| Muto, P | 1 |
| Gerding, MN | 1 |
| van der Zant, FM | 1 |
| van Royen, EA | 1 |
| Koornneef, L | 1 |
| Prummel, MF | 1 |
| Faggiano, A | 1 |
| Markl, A | 1 |
| Riedel, KG | 1 |
| Oeckler, R | 1 |
| Vogl, T | 1 |
| Scheidhauer, K | 1 |
1 review available for pentetic acid and Graves Disease
| Article | Year |
|---|---|
Clinical implications of somatostatin-receptor scintigraphy in ophthalmic Graves' disease.
Topics: Graves Disease; Humans; Indium Radioisotopes; Octreotide; Pentetic Acid; Radionuclide Imaging; Radio | 2000 |
1 trial available for pentetic acid and Graves Disease
| Article | Year |
|---|---|
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
Topics: Adult; Female; Glucocorticoids; Graves Disease; Humans; Indium Radioisotopes; Male; Methylprednisolo | 1998 |
7 other studies available for pentetic acid and Graves Disease
| Article | Year |
|---|---|
Recombinant thyrotropin-induced orbital uptake of [111In-diethylenetriamine-pentacetic acid-D-Phe1]octreotide in a patient with inactive Graves' ophthalmopathy.
Topics: Female; Graves Disease; Humans; Indium Radioisotopes; Middle Aged; Octreotide; Orbit; Pentetic Acid; | 2005 |
Increased Tc-99m DTPA uptake in active Graves' ophthalmopathy and pretibial myxoedema.
Topics: Female; Graves Disease; Humans; Leg Dermatoses; Male; Middle Aged; Myxedema; Pentetic Acid; Radionuc | 1983 |
[111In-DTPA-D-Phe1] octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity?
Topics: Eye; Eye Diseases; Graves Disease; Humans; Indium Radioisotopes; Methimazole; Octreotide; Pentetic A | 1994 |
Indium-111 octreotide in Graves' disease and in the evaluation of active exophthalmos.
Topics: Adult; Exophthalmos; Female; Graves Disease; Humans; Indium Radioisotopes; Male; Middle Aged; Octreo | 1995 |
Somatostatin-receptor scintigraphy in Graves' orbitopathy.
Topics: Graves Disease; Humans; Indium Radioisotopes; Octreotide; Pentetic Acid; Radionuclide Imaging; Recep | 1996 |
Octreotide-scintigraphy is a disease-activity parameter in Graves' ophthalmopathy.
Topics: Adult; Evaluation Studies as Topic; Female; Graves Disease; Hormones; Humans; Indium Radioisotopes; | 1999 |
[Nuclear magnetic resonance tomography of the orbits. Initial experiences using the paramagnetic contrast medium gadolinium-DTPA].
Topics: Adult; Aged; Contrast Media; Female; Gadolinium; Graves Disease; Humans; Magnetic Resonance Spectros | 1986 |